neurocare group AG
neurocare group AG, a leading innovator in personalised mental health and performance empowering clinicians to deliver best practice, has announced the appointment of Tristan de Boysson as Chairman of its Supervisory Board. The company has also welcomed Prof. Dr. Heinrich von Pierer as a Member of its Supervisory Board.
de Boysson brings over 25 years of expertise in investing and corporate leadership. He is currently a Managing Partner at TVM Capital Healthcare, a growth capital healthcare-focused private equity firm headquartered in Dubai and Singapore. His previous experience includes serving as the CEO of Amanat Holdings PJSC, one of the largest listed healthcare and education investment companies in the MENA region.
Prior to Amanat, Mr. de Boysson was a Managing Director at Investcorp, a global manager of alternative investments, where he led private equity investments in Healthcare, Industrial, Consumer & Retail and Technology companies.
Mr. de Boysson also brings experience from his time at McKinsey, where he advised on strategy and operational improvements. He holds a master’s degree in economics from ESSEC Business School, Paris, and an MBA from INSEAD.
“I am honored to join neurocare group as Chairman of the Supervisory Board, at this pivotal time in the company’s journey,” said de Boysson. “I look forward to working closely with this talented team who has developed best in class mental health treatment solutions. Together, we will build on the strong foundation laid by my predecessors and steer neurocare towards a future of continued success and industry leadership."
Prof. Dr. Heinrich von Pierer brings global leadership experience and network to the company. Beginning his career at Siemens AG in 1969, Prof. Dr. von Pierer advanced to the position of CEO of the global Siemens Group, serving from 1992 to 2005 and leading businesses in engineering, power generation, healthcare, telecommunications and finance. Subsequently he served as Siemens’ Chairman of the Supervisory Board.
Since then, Prof. Dr von Pierer has run his consultancy business and serves on the Supervisory Boards of Lennertz&Co Capital GmbH and HCE Erlangen. His vast experience also includes tenures on the supervisory boards of Deutsche Bank, Volkswagen AG, Bayer AG, Munich Re, Hochtief AG, Berenberg Bank and Koç Holding.
von Pierer said: “I see great potential in the neurocare group, its mission and current business operations around the world. By joining the supervisory board, I look forward to supporting the company in making further inroads and strategic next steps as a leading player in healthcare.”
neurocare Founder and CEO Thomas Mechtersheimer added: “The neurocare team is grateful to have the expertise of Mr. de Boysson and Prof. Dr. Heinrich von Pierer on our Supervisory Board. Personally, I am much looking forward to driving neurocare with Tristan de Boysson as our Chairman and am humbled to have access to the immense global business and leadership experience of Prof. Dr. von Pierer. This year marks exciting progress in terms of our new global leadership team recently announced, as well as our new supervisory board and funding which will position neurocare as a global leader in mental health.”
